Patents by Inventor Syunsuke Kurashita

Syunsuke Kurashita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160311895
    Abstract: Provided is a general-purpose technique capable of measuring the HbA1c content, which is comparable to the IFCC reference method. An antibody which reacts with a peptide or a protein having an amino acid sequence of VHLTPE (SEQ ID NO: 1) at the N-terminus in which the N-terminal valine is not modified, but does not react with a peptide or a protein in which the N-terminal valine of the relevant polypeptide or protein is modified.
    Type: Application
    Filed: July 13, 2016
    Publication date: October 27, 2016
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Osamu MIYAZAKI, Kohei TAKUBO, Syunsuke KURASHITA
  • Patent number: 9341633
    Abstract: There are provided a pre-treatment technique for a glycated hemoglobin-containing sample, which is a simple and convenient treatment, is free from problems in storage stability and environmental aspects, and is capable of exposing an epitope sufficiently in a short time; and an method for an immunological assay of glycated hemoglobin using this technique. A method for pre-treating a glycated hemoglobin-containing sample for an immunological assay of glycated hemoglobin, the method includes treating a glycated hemoglobin-containing sample with a pre-treatment solution containing (A) guanidine or a salt thereof and (B) a nonionic surfactant and/or a nitrite.
    Type: Grant
    Filed: December 10, 2009
    Date of Patent: May 17, 2016
    Assignee: SEKISUI MEDICAL CO., LTD.
    Inventors: Osamu Miyazaki, Syunsuke Kurashita, Kohei Takubo
  • Publication number: 20160009794
    Abstract: Provided is a general-purpose technique capable of measuring the HbA1c content, which is comparable to the IFCC reference method. An antibody which reacts with a peptide or a protein having an amino acid sequence of VHLTPE (SEQ ID NO: 1) at the N-terminus in which the N-terminal valine is not modified, but does not react with a peptide or a protein in which the N-terminal valine of the relevant polypeptide or protein is modified.
    Type: Application
    Filed: August 5, 2015
    Publication date: January 14, 2016
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Osamu MIYAZAKI, Kohei Takubo, Syunsuke Kurashita
  • Patent number: 9169320
    Abstract: Provided is a general-purpose technique capable of measuring the HbA1c content, which is comparable to the IFCC reference method. An antibody which reacts with a peptide or a protein having an amino acid sequence of VHLTPE (SEQ ID NO: 1) at the N-terminus in which the N-terminal valine is not modified, but does not react with a peptide or a protein in which the N-terminal valine of the relevant polypeptide or protein is modified.
    Type: Grant
    Filed: December 10, 2009
    Date of Patent: October 27, 2015
    Assignee: SEKISUI MEDICAL CO., LTD.
    Inventors: Osamu Miyazaki, Kohei Takubo, Syunsuke Kurashita
  • Publication number: 20110318765
    Abstract: There are provided a pre-treatment technique for a glycated hemoglobin-containing sample, which is a simple and convenient treatment, is free from problems in storage stability and environmental aspects, and is capable of exposing an epitope sufficiently in a short time; and an method for an immunological assay of glycated hemoglobin using this technique. A method for pre-treating a glycated hemoglobin-containing sample for an immunological assay of glycated hemoglobin, the method includes treating a glycated hemoglobin-containing sample with a pre-treatment solution containing (A) guanidine or a salt thereof and (B) a nonionic surfactant and/or a nitrite.
    Type: Application
    Filed: December 10, 2009
    Publication date: December 29, 2011
    Applicant: Sekisui Medical Co., Ltd.
    Inventors: Osamu Miyazaki, Syunsuke Kurashita, Kohei Takubo
  • Publication number: 20110311989
    Abstract: Provided is a general-purpose technique capable of measuring the HbA1c content, which is comparable to the IFCC reference method. An antibody which reacts with a peptide or a protein having an amino acid sequence of VHLTPE (SEQ ID NO: 1) at the N-terminus in which the N-terminal valine is not modified, but does not react with a peptide or a protein in which the N-terminal valine of the relevant polypeptide or protein is modified.
    Type: Application
    Filed: December 10, 2009
    Publication date: December 22, 2011
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Osamu Miyazaki, Kohei Takubo, Syunsuke Kurashita